Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome

OBJECTIVE: To evaluate the indication and performance of systematic lymphadenectomy (SL) in Stage I endometrioid endometrial carcinoma (EEC), at intermediate risk (FIGO IAG2/G3, IBG1/G2) on recurrence, disease-free survival (DFS) and survival. STUDY DESIGN: 194 women underwent hysterectomies by lapa...

Descripción completa

Detalles Bibliográficos
Autores principales: Candido, Elaine C., Rangel Neto, Osmar F., Toledo, Maria Carolina S., Torres, José Carlos C., Cairo, Aurea A.A., Braganca, Joana F., Teixeira, Julio C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Gynaecology: Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687380/
https://www.ncbi.nlm.nih.gov/pubmed/31403112
http://dx.doi.org/10.1016/j.eurox.2019.100020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687380/
https://www.ncbi.nlm.nih.gov/pubmed/31403112
http://dx.doi.org/10.1016/j.eurox.2019.100020

Ejemplares similares